Mechanisms and therapeutic targeting of NT5C2 mutations in relapsed acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is an aggressive hematologic malignancy that results from the unregulated growth of B-cell and T-cell lymphoid progenitors. Despite the implementation of risk-stratification and improved multi-agent therapeutic regimens, 20% of pediatric and 50% of adult patients f...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://doi.org/10.7916/d8-y5g9-9573 |